Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-18-001610

CEO acquired 166,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-11-07 Grant or award : show line 1 in the form +166,667 1,259,908 D
Loading xslF345X03/form4-11092018_021156.xml…